These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 27559435)
1. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. Lee JM; Lee HS; Hyun JJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD World J Gastrointest Oncol; 2016 Jul; 8(7):555-62. PubMed ID: 27559435 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715 [No Abstract] [Full Text] [Related]
3. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
5. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
6. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
7. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Wu M; Guo J; Guo L; Zuo Q Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157 [TBL] [Abstract][Full Text] [Related]
8. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients. Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma. Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio Chen Y; Liao Y; Lam LM; He L; Tsang YS; Di YS; Liang ST; Xia Q Int J Med Sci; 2020; 17(10):1449-1457. PubMed ID: 32624701 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Mao M; Wei X; Sheng H; Chi P; Liu Y; Huang X; Xiang Y; Zhu Q; Xing S; Liu W Oncol Lett; 2017 Dec; 14(6):7417-7424. PubMed ID: 29344182 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578 [TBL] [Abstract][Full Text] [Related]
16. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy. Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer? Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926 [TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients. Zhang WW; Liu KJ; Hu GL; Liang WJ Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409 [TBL] [Abstract][Full Text] [Related]
20. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]